Perspectives on current approaches to virtual screening in drug discovery
Introduction For the past two decades, virtual screening (VS) has been an efficient hit finding
approach for drug discovery. Today, billions of commercially accessible compounds are …
approach for drug discovery. Today, billions of commercially accessible compounds are …
Fusing sequence and structural knowledge by heterogeneous models to accurately and interpretively predict drug–target affinity
X Zeng, KY Zhong, B Jiang, Y Li - Molecules, 2023 - mdpi.com
Drug–target affinity (DTA) prediction is crucial for understanding molecular interactions and
aiding drug discovery and development. While various computational methods have been …
aiding drug discovery and development. While various computational methods have been …
Synthesis of Pyrrolo[3,4-b]pyridin-5-ones via Ugi–Zhu Reaction and In Vitro–In Silico Studies against Breast Carcinoma
I Morales-Salazar, CE Garduño-Albino… - Pharmaceuticals, 2023 - mdpi.com
An Ugi–Zhu three-component reaction (UZ-3CR) coupled in a one-pot manner to a cascade
process (N-acylation/aza Diels–Alder cycloaddition/decarboxylation/dehydration) was …
process (N-acylation/aza Diels–Alder cycloaddition/decarboxylation/dehydration) was …
Targeting ERK-MYD88 interaction leads to ERK dysregulation and immunogenic cancer cell death
F Virard, S Giraud, M Bonnet, L Magadoux… - Nature …, 2024 - nature.com
The quest for targeted therapies is critical in the battle against cancer. The RAS/MAP kinase
pathway is frequently implicated in neoplasia, with ERK playing a crucial role as the most …
pathway is frequently implicated in neoplasia, with ERK playing a crucial role as the most …
Allosteric inhibition of NMDA receptors by low dose ketamine
JA Abbott, H Wen, B Liu, SS Gupta, GJ Iacobucci… - Molecular …, 2024 - nature.com
Ketamine, a general anesthetic, has rapid and sustained antidepressant effects when
administered at lower doses. Anesthetic levels of ketamine reduce excitatory transmission …
administered at lower doses. Anesthetic levels of ketamine reduce excitatory transmission …
Exploring optimal drug targets through subtractive proteomics analysis and pangenomic insights for tailored drug design in tuberculosis
Tuberculosis (TB), caused by Mycobacterium tuberculosis, ranks among the top causes of
global human mortality, as reported by the World Health Organization's 2022 TB report. The …
global human mortality, as reported by the World Health Organization's 2022 TB report. The …
Discovery of Novel 1-Phenylpiperidine Urea-Containing Derivatives Inhibiting β-Catenin/BCL9 Interaction and Exerting Antitumor Efficacy through the Activation of …
W Zhu, C Liu, K Xi, A Li, L Shen, Y Li… - Journal of Medicinal …, 2024 - ACS Publications
Aberrant activation of the Wnt/β-catenin signaling is associated with tumor development, and
blocking β-catenin/BCL9 is a novel strategy for oncogenic Wnt/β-catenin signaling. Herein …
blocking β-catenin/BCL9 is a novel strategy for oncogenic Wnt/β-catenin signaling. Herein …
Structure-guided discovery of novel AflG inhibitors for aflatoxin contamination control in aspergillus flavus
F Wang, W Zhou, M Yang, J Niu, W Huang… - Frontiers in …, 2024 - frontiersin.org
Aflatoxins (AFs) are highly carcinogenic metabolites produced by Aspergillus species that
can contaminate critical food staples, leading to significant health and economic risks. The …
can contaminate critical food staples, leading to significant health and economic risks. The …
Quantum mechanical analysis of newly synthesized HIV-1 protease inhibitors: evaluation of wild-type and resistant strain binding interactions
GVR Silva, KAR Reiniger… - Physical Chemistry …, 2024 - pubs.rsc.org
Inhibition of HIV-1 protease is a cornerstone of antiretroviral therapy. However, the notorious
ability of HIV-1 to develop resistance to protease inhibitors (PIs), particularly darunavir …
ability of HIV-1 to develop resistance to protease inhibitors (PIs), particularly darunavir …
[HTML][HTML] Efficient Generation of Protein Pockets with PocketGen
Designing protein-binding proteins is critical for drug discovery. However, the AI-based
design of such proteins is challenging due to the complexity of ligand-protein interactions …
design of such proteins is challenging due to the complexity of ligand-protein interactions …